Portal de Periódicos da CAPES

Ovarian Cancer After Breast Cancer Treatment: Study of 03 Cases in a Guinean Oncological Setting

2023; Science Publishing Group; Linguagem: Inglês

10.11648/j.crj.20231103.14

2330-8214

Bah Malick, Touré Alhassane Ismael, Keita Mamady, Cisse Kalil, Souare Mamadou Bobo, Conde Ibrahima Kalil, Cissé Mohamed Falilou, Traoré Bangaly,

Ovarian cancer diagnosis and treatment

Introduction: Ovarian cancer, the 1st cause of death from gynecological cancer, is any malignant proliferative process developed in the ovary, which may occur after a treated breast cancer. Objectives: To discuss the management and prognosis of ovarian cancer after breast cancer treatment through a series of 3 clinical cases in a Guinean oncology setting. Case 1: A 60-year-old patient presented with an ulcerating tumor of the uterine cervix, after treatment of a CCI, she benefited from 12 courses of palliative chemotherapy and died 04 months after her last course with decompensated anemia. Case 2: the 75-year-old female patient who presented with abdominal distension with ascites associated with a pelvic mass after treatment of a CCI, died of multivisceral failure. Case 3: A 61-year-old hypertensive diabetic patient presented with abdominal distension and a pelvic-abdominal mass. After treatment of a CCI, she underwent an exploratory laparotomy and died at D15 post-op in hypovolaemic shock. Conclusion: This study shows the need to include monitoring of gynecological organs in patients treated for breast cancer. The diagnosis was late and the prognosis was poor.